[Press Release] Recently, Eternity Biotechnology Co., Ltd. was officially appointed as the Deputy Secretary-General Unit of the Dongguan Biotechnology Industry Association. The awarding ceremony was grandly held at the company's headquarters. Song Tao, Chairman of Dongguan Biotechnology Industry Development Co., Ltd. and Executive President of the Dongguan Biotechnology Industry Association, led a delegation including Li Xiaolong, Director and Deputy General Manager of Dongguan Biotechnology Industry Development Co., Ltd.; Yu Jie, Secretary-General of the Dongguan Biotechnology Industry Association; and Zhang Xubiao, Investment Promotion Director of Dongguan Biotechnology Industry Development Co., Ltd., to visit Eternity Biotechnology. The two parties engaged in in-depth discussions on technological collaboration and industrial development, jointly exploring the prospects of cooperation in the biotechnology sector.
Grand Awarding Ceremony Recognizes Industry Standing
At the ceremony, President Song, on behalf of the Dongguan Biotechnology Industry Association, officially awarded Eternity Biotechnology the title of "Deputy Secretary-General Unit," signifying the company's contributions and influence in the biotechnology field have been highly recognized by the industry. In his speech, President Song stated, " Eternity Biotechnology has achieved remarkable results in the cultivation, R&D, and industrial application of Antrodia cinnamomea, demonstrating outstanding technological innovation capabilities and market potential. This appointment not only affirms the company's strengths but also represents a significant step in promoting collaborative development within the industry."
Gary Lo , Director and CEO of Eternity Biotechnology, expressed, "Becoming the Deputy Secretary-General Unit of the Dongguan Biotechnology Industry Association is both an honor and a responsibility. Moving forward, we will actively leverage our technological advantages to collaborate closely with the Association and its members, jointly driving innovation and development in the biotechnology industry."
Deepening Technological Collaboration for Industrial Growth
During the subsequent discussion forum, the two parties exchanged views on topics such as the industrial application and market promotion of Antrodia cinnamomea. Song Tao, Chairman of Dongguan Biotechnology Industry Development Co., Ltd., praised Eternity Biotechnology 's scientific research capabilities and expressed hopes for deeper cooperation in areas such as technological R&D, commercialization of achievements, and market expansion.
As a high-tech enterprise specializing in the cultivation and biotechnological application of Antrodia cinnamomea, Eternity Biotechnology has accumulated extensive experience in strain selection and industrial cultivation over the years. Its products have gained widespread recognition in domestic and international markets for their exceptional quality. The deepened collaboration with the Dongguan Biotechnology Industry Association will further accelerate the industrialization of technological achievements and support the high-quality development of the biotechnology sector.
Looking Ahead: Joint Efforts to Create a New Chapter
The awarding ceremony and exchange activities not only strengthened Eternity Biotechnology 's ties with the industry association and peer enterprises but also laid a solid foundation for future cooperation. In the future, Eternity Biotechnology will continue to uphold the principles of "Quality, Professionalism, Technology, and Innovation," deepen industry-academia-research collaboration, and promote the application of Antrodia cinnamomea technology in fields such as healthcare and functional foods, injecting new momentum into the biotechnology industry.
With the rapid development of the biotechnology sector, Eternity Biotechnology will seize this appointment as an opportunity to join hands with industry partners in exploring broader market prospects, contributing to the implementation of the Healthy China strategy.
